Filter posts

Innovation Act Threatens Biotech Innovation

BIO has grave concerns regarding the Innovation Act (H.R. 3309), as reported by the House Judiciary Committee. …

Patents Improve Public Health: Progressive Economy Reviews TRIPS at 20 Years

Progressive Economy released a research paper examining the effect of TRIPS (Trade-Related Aspects of Intellectual …

South Africa National Policy on Intellectual Property: Inconsistent with Biotech Development Goals

BIO submitted comments this week to the government of South Africa on their proposed “Draft …

New Bill Calls for No WTO-Plus Benefits for Countries that Violate IP

A new Bill in the U.S. House of Representatives seeks to remove WTO-plus trade benefits …

Patent Trolls and Patent Litigation: The GAO Weighs In

Patent troll litigation alarmist were likely disappointed by the GAO report.  While the public discourse …

What a Patent is Not

‘Patent trolls.’  ‘Patients over patents.’  ‘Do Not Patent My Genes.’  ‘Patents ate my baby.’  Ok, …

TPP and Innovation in the Bioeconomy: The Need for 12 Years of Data Protection

A few weeks ago, BIO submitted a letter and white paper (PDF) to the U.S. Trade Representative outlining recommendations …

Patent Docs Highlights the BIO IPDx Symposium

Patent Docs recently highlighted McDonnell Boehnen Hulbert & Berghoff’s (MBHB) panel at BIO’s IP and …

IP in Latin America: Growing Recognition of the Importance of IP to Innovation

The Inter-American Dialogue’s daily Latin America Advisor recently asked the question “How seriously do Latin …

Session Summary: What Every CEO Must Know About IP In Biotech

On Sunday, April 21st, 2013, I attended a standing room only session titled, “What Every …